EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

New trends in Multiple Myeloma management is to look for the few amounts of cancer cells that might remain in your bone marrow. These residual cells are responsible of the disease relapse. Myeloma Patients Europe will hold an online webinar on Minimal Residual Disease (MRD) that will highlight the importance of this monitoring method and will detail new highly sensitive techniques used to investigate it.

The talk will be given by Dr Bruno Paiva, Director of the Flow Cytometry Unit CIMA, University of Navarra Pamplona in Spain.

The webinar will take place on 2 May 2016 (9:00-10:30 CET). The session will last about 90 minutes, including a 50 minute presentations Dr. Paiva and a 40 minute Q/A session at the end.

Registration is free of charge. Also, feel free to forward the registration link to anyone who might be interested in attending the webinar.

Should you be unable to attend the webinar, please feel free to send your questions in advance to info@mpeurope.org and we will make sure they reach our speakers.

A recording of the webinar will be available shortly after the session.

We look forward to your participation.

Join this webinar







Recent news

» Horizon2020 CARAMBA Myeloma Pipeline information sheet now available in five languages

» The FDA approves the first anti-BCMA CAR-T Cell Therapy for myeloma, idecabtagene vicleucel (Abecma)

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.